Leicester receives world-class bioscience investment
Our University has been awarded over £1.5million in order to advance knowledge and understanding in three key areas that impact on health.
The funding has come from the Biotechnology and Biological Sciences Research Council (BBSRC), which leads world-class 21st century bioscience, promoting innovation in the bioeconomy and realising benefits for society within and beyond the UK.
Three groups from Leicester have won awards. They are led by:
- Professor David Lambert, £338,432, Department of Cardiovascular Sciences - Professor Lambert and his team have designed a novel ‘biosensor’ to observe the release of nociceptin from single living immune cells - which has never been done before.
- Professor Marco Rinaldo Oggioni, £700,532, Department of Genetics - Professor Oggioni is investigating the spread of infection.
- Dr Shaun Cowley, £507,945, Department of Molecular and Cell Biology - Dr Cowley is conducting research into a class of enzymes called HDACs (histone deacetylases) which help regulate access to the information stored within our DNA.
The projects cover a wide range of subjects that impact on human health, including sepsis; the spread of infections; and cancer amongst other things.